Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A PHASE I/II TRIAL OF COMBINATION NAB-PACLITAXEL AND NINTEDANIB OR NAB-PACLITAXEL AND PLACEBO IN RELAPSED NSCLC ADENOCARCINOMA
Epistemonikos ID: 74b349ea9d0d9a3adb6ac1fa98a0d9101be03a9c
First added on: May 21, 2024